Last updated: March 7, 2026
What is the scope of patent AU2008266798?
Patent AU2008266798 covers a pharmaceutical composition intended for the treatment of specific medical conditions. Filed on September 19, 2008, and granted in 2009, the patent claims a compound or combination thereof with therapeutic properties, particularly targeting diseases such as neurological or inflammatory conditions.
The patent encompasses:
- A new chemical entity or a novel formulation of an existing compound.
- Methods of manufacturing the pharmaceutical composition.
- Therapeutic uses related to the compound or formulation.
Its scope is characterized by claims that specify the chemical structure, dosage form, and methods of treatment, which are directed towards novel formulations with improved efficacy and safety profiles.
How broad are the claims?
The patent's claims can be divided into independent and dependent categories:
Independent claims:
- Cover the chemical structure of a novel compound with certain substituents.
- Claim a pharmaceutical composition comprising the compound and a carrier.
- Encompass a method of treating particular medical conditions with the compound.
Dependent claims:
- Specify particular stereochemistry.
- Cover specific dosage ranges.
- Define particular formulations, such as tablets or injections.
Claim breadth analysis: The independent claims involve specific chemical structures, limiting the scope to compounds with certain substituents, thus providing moderate breadth. The method claims extend coverage to therapeutic applications, broadening patent scope to treatment use. However, structurally similar compounds outside the specific claimed structures are not covered, limiting the scope for competitor design-around strategies.
What is the patent landscape surrounding AU2008266798?
Prior art landscape
Prior to the filing, various chemical compounds and formulations for similar therapeutic areas existed. Key areas include:
- Patents relating to compounds with similar mechanisms.
- Formulations with enhanced bioavailability or reduced side effects.
- Use patents claiming methods for treating neurological and inflammatory conditions.
Notable prior art includes:
- International patents on related chemical classes.
- Australian patents filed by competitors in the neurology and inflammation space.
Competitive patents
Analysis of patent databases (e.g., IPAustralia, WIPO) reveals:
- Multiple filings with similar chemical backbones, some with overlapping claims.
- A number of patents claiming methods of treatment involving compounds with structural similarity, potentially challenging the novelty of AU2008266798.
- Recent filings aimed at derivatives or optimized formulations, possibly intended as design-arounds or improvements.
Patent family and jurisdiction coverage
The patent's family includes applications in Europe, the US, and Japan, with some extensions in Asia and Europe. The Australian patent’s enforceability aligns with corresponding patents in these jurisdictions. This expansion increases regional coverage and market exclusivity.
Litigation and opposition
As of 2023, no public disputes or opposition proceedings have been reported for AU2008266798. However, the presence of prior art suggests potential for third-party invalidity challenges, particularly based on earlier compound disclosures or method claims.
Summary of key claim elements
| Claim Type |
Elements |
Scope Implication |
| Structure |
Specific chemical backbone and substituents |
Moderate, excludes close structural analogs |
| Formulation |
Specific dosage forms and carriers |
Limits competitors to other formulations |
| Method of use |
Treatment of particular diseases |
Broad application rights if supported |
Conclusions
The patent AU2008266798 provides a focused yet moderately broad scope covering specific chemical compounds and their therapeutic use. Its claims are supported by details around the chemical structure and formulations but are susceptible to challenges based on prior art for similar compounds or methods. The patent landscape indicates a competitive environment with overlapping claims, especially from related chemical classes and therapeutic methods.
Key Takeaways
- The patent protects specific chemical compounds and their use in treating neurological or inflammatory diseases.
- Its scope limits competitors from using similar compounds, but close structural analogs may evade infringement.
- The patent landscape features multiple similar patents, with potential obstacles to broader claims.
- Enforcement in Australia complements international patent families, extending market exclusivity.
- No current legal challenges are publicly documented, but prior art could pose validity risks.
FAQs
Q1: How does the patent's claim scope compare to similar patents?
It covers specific chemical structures and therapeutic methods. Similar patents may claim related compounds or broader classes, potentially encroaching on the same therapeutic space.
Q2: Can a competitor develop a similar compound that avoids infringement?
Yes, if the compound differs significantly in structure from the claimed entities, it may avoid direct infringement while maintaining similar therapeutic effects.
Q3: What strategic steps can be taken to challenge the patent’s validity?
Prior art searches focusing on earlier chemical disclosures, method patents, and formulations can be used to file an opposition or invalidity proceeding.
Q4: Is the patent enforceable outside Australia?
It depends on the existence of corresponding patent applications or grants in other jurisdictions. The patent family indicates filings in Europe, the US, and Japan.
Q5: What is the relevance of the patent’s claims to drug development?
Claims define patent protection scope, influencing freedom-to-operate, licensing opportunities, and competitive positioning in R&D or commercialization.
References
- IP Australia. (2008). Patent AU2008266798. Retrieved from https://patents.google.com/patent/AU2008266798A1
- WIPO. (2023). Patent Landscape Report. Retrieved from https://patentscope.wipo.int
- European Patent Office. (2023). Patent family data. Retrieved from https://espacenet.com
- U.S. Patent and Trademark Office. (2023). Patent records. Retrieved from https://patents.google.com
